Takeda Pharmaceuticals says it is committed to saving the lives of five million children each year and describes initiatives in child health.
Access Takeda's directory of downloadable reports on sustainability, corporate overview, and annual reports.
Entyvio Shows Higher Rates of Mucosal Healing Versus TNFα-Antagonist Therapy in Real-World Data Analysis
OSAKA, Japan, and CAMBRIDGE, Massachusetts, July 9, 2025 – Takeda (TSE:4502/NYSE:TAK) today filed its Corporate Governance Report with the Tokyo Stock Exchange (“TSE”) in accordance with the regulations for TSE listed companies.
Takeda describes a shared purpose and an aspiration to contribute to something bigger than any one person.
The page describes the composition and purpose of Takeda Pharmaceuticals’ Board of Directors, which oversees strategic decisions.
The Takeda leadership team is committed to developing and executing strategy with patients at the center.
Rhonda Pacheco is President of Takeda’s U.S. Business Unit and U.S. Country Head, and a member of Takeda’s Executive Team.
Takeda’s vision is to discover and deliver treatments guided by its commitments to patients, its people, and the planet.
The company’s papers outline its position on material issues that arise in realizing its purpose and vision.
Introducing Takeda Garden for Medicinal Plant Conservation, Kyoto.
Takeda Pharmaceutical Company Limited provides its global corporate address and contact information for media inquiries, investor relations, comments, and questions. The page also references FAQs and a Privacy Notice.
Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
The page states that using the site represents consent to its terms and conditions.
